|
US3926891A
(en)
|
1974-03-13 |
1975-12-16 |
Dow Chemical Co |
Method for making a crosslinkable aqueous solution which is useful to form soft, water-swellable polyacrylate articles
|
|
US3935099A
(en)
|
1974-04-03 |
1976-01-27 |
The United States Of America As Represented By The Secretary Of Agriculture |
Method of reducing water content of emulsions, suspensions, and dispersions with highly absorbent starch-containing polymeric compositions
|
|
US3997484A
(en)
|
1974-04-03 |
1976-12-14 |
The United States Of America As Represented By The Secretary Of Agriculture |
Highly-absorbent starch-containing polymeric compositions
|
|
US4090013A
(en)
|
1975-03-07 |
1978-05-16 |
National Starch And Chemical Corp. |
Absorbent composition of matter
|
|
JPS51125468A
(en)
|
1975-03-27 |
1976-11-01 |
Sanyo Chem Ind Ltd |
Method of preparing resins of high water absorbency
|
|
JPS5346389A
(en)
|
1976-10-07 |
1978-04-25 |
Kao Corp |
Preparation of self-crosslinking polymer of acrylic alkali metal salt
|
|
US4190562A
(en)
|
1977-04-04 |
1980-02-26 |
The B. F. Goodrich Company |
Improved water absorbent copolymers of copolymerizable carboxylic acids and acrylic or methacrylic esters
|
|
US4470975A
(en)
|
1977-10-21 |
1984-09-11 |
The Johns Hopkins University |
Method and composition for the elimination of water from an animal body
|
|
US4286082A
(en)
|
1979-04-06 |
1981-08-25 |
Nippon Shokubai Kagaku Kogyo & Co., Ltd. |
Absorbent resin composition and process for producing same
|
|
JPS6025045B2
(ja)
|
1980-03-19 |
1985-06-15 |
製鉄化学工業株式会社 |
塩水吸収能のすぐれたアクリル酸重合体の製造方法
|
|
JPS57158209A
(en)
|
1981-03-25 |
1982-09-30 |
Kao Corp |
Production of bead-form highly water-absorbing polymer
|
|
JPS5832607A
(ja)
|
1981-08-20 |
1983-02-25 |
Kao Corp |
吸水性に優れた吸水材料の製造法
|
|
US4985518A
(en)
|
1981-10-26 |
1991-01-15 |
American Colloid Company |
Process for preparing water-absorbing resins
|
|
JPS6187702A
(ja)
|
1984-10-05 |
1986-05-06 |
Seitetsu Kagaku Co Ltd |
吸水性樹脂の製造方法
|
|
US4708997A
(en)
|
1985-07-22 |
1987-11-24 |
The Dow Chemical Company |
Suspending agent for the suspension polymerization of water-soluble monomers
|
|
US4806532A
(en)
|
1985-10-08 |
1989-02-21 |
Mayo Foundation For Medical Education And Research |
Inhibition of epithelial phosphate transport
|
|
DE3544770A1
(de)
|
1985-12-18 |
1987-06-19 |
Stockhausen Chem Fab Gmbh |
Verfahren und vorrichtung zum kontinuierlichen herstellen von polymerisaten und copolymerisaten der acrylsaeure und/oder methacrylsaeure
|
|
US4766004A
(en)
|
1986-12-19 |
1988-08-23 |
Warner-Lambert Company |
Crunchy, highly palatable, bulk-increasing, dietary fiber supplement composition
|
|
IT1217123B
(it)
|
1987-02-05 |
1990-03-14 |
Rotta Research Lab |
Derivati otticamente attivi dell acido 5 pentilammino 5 oxo pentanoico r ad attivita antagonista della colecistochinina e procedimento per la loro preparazione
|
|
US4999200A
(en)
|
1987-12-09 |
1991-03-12 |
Marion Laboratories |
Psyllium tablet composition, method of manufacture and method of use
|
|
US5149541A
(en)
|
1988-10-03 |
1992-09-22 |
The Procter & Gamble Company |
Psyllium-containing produces with a distribution of particle size
|
|
US5145906A
(en)
|
1989-09-28 |
1992-09-08 |
Hoechst Celanese Corporation |
Super-absorbent polymer having improved absorbency properties
|
|
US5126150A
(en)
|
1990-10-01 |
1992-06-30 |
The Procter & Gamble Company |
Compositions containing psyllium
|
|
HUT64023A
(en)
|
1991-03-22 |
1993-11-29 |
Sandoz Ag |
Process for producing aminoguanidine derivatives and pharmaceutical compositions comprising such compounds
|
|
FR2674849B1
(fr)
|
1991-04-02 |
1994-12-23 |
Logeais Labor Jacques |
Nouveaux derives de n-cyclohexyl benzamides ou thiobenzamides, leurs preparations et leurs applications en therapeutique.
|
|
US5140102A
(en)
|
1991-09-23 |
1992-08-18 |
Monsanto Company |
Pentadecapeptide, guanylin, which stimulates intestinal guanylate cyclase
|
|
SG50624A1
(en)
|
1991-12-30 |
1998-07-20 |
Neurex Corp |
Methods of producing analgesia and enhancing opiate analgesia
|
|
US5824645A
(en)
|
1991-12-30 |
1998-10-20 |
Neurex Corporation |
Method of treating inflammation
|
|
US5969097A
(en)
|
1992-06-23 |
1999-10-19 |
G. D. Searle & Co. |
Human guanylin
|
|
DK0612723T3
(da)
|
1993-02-20 |
1998-03-30 |
Hoechst Ag |
Substituerede benzoylguanidiner, fremgangsmåde til fremstilling, deres anvendelse som lægemiddel, som inhibitor af den cellulære Na+/H+-udbytning eller som diagnostikum samt lægemiddel med indhold deraf
|
|
US5629377A
(en)
|
1993-03-10 |
1997-05-13 |
The Dow Chemical Company |
Water absorbent resin particles of crosslinked carboxyl containing polymers and method of preparation
|
|
IL109570A0
(en)
|
1993-05-17 |
1994-08-26 |
Fujisawa Pharmaceutical Co |
Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
|
|
US5489670A
(en)
|
1993-10-29 |
1996-02-06 |
G. D. Searle & Co. |
Human uroguanylin
|
|
US7357946B2
(en)
|
1994-04-15 |
2008-04-15 |
Adamoli Jr James R |
Uses for cellulose-containing aggregates
|
|
US5610145A
(en)
|
1994-04-15 |
1997-03-11 |
Warner-Lambert Company |
Tachykinin antagonists
|
|
US5650222A
(en)
|
1995-01-10 |
1997-07-22 |
The Procter & Gamble Company |
Absorbent foam materials for aqueous fluids made from high internal phase emulsions having very high water-to-oil ratios
|
|
DE19518796A1
(de)
|
1995-05-22 |
1996-11-28 |
Hoechst Ag |
Fluorphenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
|
DE69627153T2
(de)
|
1995-06-27 |
2003-12-04 |
Elan Pharmaceuticals, Inc.(N.D.Ges.D.Staates Delaware) |
Zusammensetzungen zur erzielung von analgesie und zur hemmung der progression neuropathischer schmerzerkrankungen
|
|
US6054429A
(en)
|
1996-03-08 |
2000-04-25 |
Elan Pharmaceuticals, Inc. |
Epidural method of producing analgesia
|
|
US5795864A
(en)
|
1995-06-27 |
1998-08-18 |
Neurex Corporation |
Stable omega conopetide formulations
|
|
US5550167A
(en)
|
1995-08-30 |
1996-08-27 |
The Procter & Gamble Company |
Absorbent foams made from high internal phase emulsions useful for acquiring aqueous fluids
|
|
GB9524104D0
(en)
|
1995-11-24 |
1996-01-24 |
Smithkline Beecham Spa |
Novel compounds
|
|
EA002124B1
(ru)
|
1995-11-24 |
2001-12-24 |
Смитклайн Бичам С.П.А. |
Производные хинолина
|
|
DE19548812A1
(de)
|
1995-12-27 |
1997-07-03 |
Hoechst Ag |
Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikaments zur Atemstimulation
|
|
EP0837055A1
(en)
|
1996-07-30 |
1998-04-22 |
Hoechst Aktiengesellschaft |
Substituted Indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them
|
|
DE19633966A1
(de)
|
1996-08-22 |
1998-02-26 |
Hoechst Ag |
Phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
|
AU4176997A
(en)
|
1996-09-16 |
1998-04-02 |
Warner-Lambert Company |
3-alkyl-3-phenyl-piperidines
|
|
AU6823098A
(en)
|
1997-02-28 |
1998-09-18 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Synergistic combination of pde inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists
|
|
NZ329807A
(en)
|
1997-04-23 |
2000-07-28 |
Pfizer |
NK-1 receptor antagonists and P receptor antagonists 2-Diarylmethyl-3-amino-1-azabicyclo[2.2.2]octane derivatives and amino substituted N-containing rings as agents for treating irritable bowel syndrome
|
|
KR100219918B1
(ko)
|
1997-07-03 |
1999-09-01 |
김윤 |
대장선택적 약물전달용 조성물
|
|
US20010006972A1
(en)
|
1998-04-21 |
2001-07-05 |
Stephen A. Williams |
Nk-1 receptor antagonists for the treatment of symptoms of irritable bowel syndrome
|
|
KR20000011247A
(ko)
|
1998-07-23 |
2000-02-25 |
김윤 |
다당류를이용한대장선택성약물전달조성물및약학제제
|
|
DE19849722A1
(de)
|
1998-10-28 |
2000-05-04 |
Aventis Pharma Gmbh |
Substituierte Phenyl-alkenoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
|
HK1041703A1
(zh)
|
1999-01-21 |
2002-07-19 |
Board Of Regents The University Of Texas System |
肠道顶膜钠/磷酸盐共同传送的抑制剂
|
|
FR2789493B1
(fr)
|
1999-02-09 |
2001-03-09 |
Gemplus Card Int |
Procede de detection d'objets portables et systeme de mise en oeuvre
|
|
US6624150B2
(en)
|
1999-02-26 |
2003-09-23 |
Inspire Pharmaceuticals, Inc. |
Method of treating gastrointestinal tract disease with purinergic receptor agonists
|
|
US6287609B1
(en)
|
1999-06-09 |
2001-09-11 |
Wisconsin Alumni Research Foundation |
Unfermented gel fraction from psyllium seed husks
|
|
KR20020038694A
(ko)
|
1999-07-19 |
2002-05-23 |
프란시스 제이 메이어 |
소듐 채널 차단제의 콘쥬게이트 및 그 이용방법
|
|
CO5190714A1
(es)
|
1999-07-20 |
2002-08-29 |
Smithkline Beecham Corp |
Inhibidores del transporte de fosfato
|
|
US6107356A
(en)
|
1999-08-23 |
2000-08-22 |
The Procter & Gamble Company |
High suction polymeric foam materials
|
|
DE19941764A1
(de)
|
1999-09-02 |
2001-03-15 |
Aventis Pharma Gmbh |
Substituierte Acylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikamente oder Diagnostika sowie sie enthaltende Medikamente
|
|
SE9903291D0
(sv)
|
1999-09-15 |
1999-09-15 |
Astra Ab |
New process
|
|
DE19945302A1
(de)
|
1999-09-22 |
2001-03-29 |
Merck Patent Gmbh |
Biphenylderivate als NHE-3-Inhibitoren
|
|
US6887870B1
(en)
|
1999-10-12 |
2005-05-03 |
Bristol-Myers Squibb Company |
Heterocyclic sodium/proton exchange inhibitors and method
|
|
AU776567B2
(en)
|
1999-11-01 |
2004-09-16 |
Evans, Brian K |
Composition for treatment of constipation and irritable bowel syndrome
|
|
AUPQ514600A0
(en)
|
2000-01-18 |
2000-02-10 |
James Cook University |
Brain injury treatment
|
|
AU3580001A
(en)
|
2000-03-01 |
2001-09-12 |
University College London |
Modulators of the endocannabinoid uptake and of the vallinoid receptors
|
|
DE10015248A1
(de)
|
2000-03-28 |
2001-10-04 |
Merck Patent Gmbh |
Bisamidino-Verbindungen als NHE-3 Inhibitoren
|
|
DE10019062A1
(de)
|
2000-04-18 |
2001-10-25 |
Merck Patent Gmbh |
2-Guanidino-4-aryl-chinazoline als NHE-3 Inhibitoren
|
|
US20030212074A1
(en)
|
2000-05-02 |
2003-11-13 |
Dimitri Gaitanopoulos |
Phosphate transport inhibitors
|
|
CZ20023701A3
(cs)
|
2000-05-12 |
2003-11-12 |
Smithkline Beecham Corporation |
Inhibitory transportu fosfátu
|
|
US6414016B1
(en)
|
2000-09-05 |
2002-07-02 |
Sucampo, A.G. |
Anti-constipation composition
|
|
DE10043667A1
(de)
|
2000-09-05 |
2002-03-14 |
Merck Patent Gmbh |
2-Guanidino-4-aryl-chinazoline
|
|
DE10046993A1
(de)
|
2000-09-22 |
2002-04-11 |
Aventis Pharma Gmbh |
Substituierte Zimtsäureguanidide, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltendes Medikament
|
|
AU2002213048A1
(en)
|
2000-10-05 |
2002-04-15 |
Smith Kline Beecham Corporation |
Phosphate transport inhibitors
|
|
AU2002232955A1
(en)
|
2000-11-20 |
2002-05-27 |
Dow Global Technologies Inc. |
In vivo use of water absorbent polymers
|
|
DE10063294A1
(de)
|
2000-12-19 |
2002-07-04 |
Aventis Pharma Gmbh |
Substituierte Heterocyclo-Norbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
|
CN103641892B
(zh)
|
2001-03-29 |
2015-06-17 |
药物协和公司 |
用于治疗组织炎症和癌变的鸟苷酸环化酶受体激动剂
|
|
US6736705B2
(en)
|
2001-04-27 |
2004-05-18 |
Hitachi Global Storage Technologies |
Polishing process for glass or ceramic disks used in disk drive data storage devices
|
|
US20030216449A1
(en)
*
|
2001-05-11 |
2003-11-20 |
Joseph Weinstock |
Phosphate transport inhibitors
|
|
MY134211A
(en)
|
2001-05-18 |
2007-11-30 |
Smithkline Beecham Corp |
Novel use
|
|
JP2007131532A
(ja)
|
2001-09-28 |
2007-05-31 |
Kirin Brewery Co Ltd |
生体内リン輸送を阻害する化合物およびそれを含んでなる医薬
|
|
FR2830451B1
(fr)
|
2001-10-09 |
2004-04-30 |
Inst Nat Sante Rech Med |
Utilisation de peptides analogues de la thymuline(pat)pour la fabrication de medicaments contre la douleur
|
|
AU2002354410A1
(en)
|
2001-12-05 |
2003-06-17 |
Japan Tobacco Inc. |
Triazole compound and medicinal use thereof
|
|
US6911453B2
(en)
|
2001-12-05 |
2005-06-28 |
Aventis Pharma Deutschland Gmbh |
Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them
|
|
HRP20040507A2
(en)
|
2001-12-05 |
2005-08-31 |
Aventis Pharma Deutschland Gmbh |
Substituted 4-phenyltetrahydroisoquinoline methods
|
|
DE10161767A1
(de)
|
2001-12-15 |
2003-06-26 |
Merck Patent Gmbh |
2-Guanidino-4-heterocyclyl-chinazoline
|
|
EP1321142A1
(en)
|
2001-12-21 |
2003-06-25 |
Novartis AG |
Solid pharmaceutical composition for oral administration of Tegaserod
|
|
US6703405B2
(en)
|
2001-12-22 |
2004-03-09 |
Aventis Pharma Deutschland Gmbh |
Substituted 4-phenyltetrahydroisoquinolinium salts, process for their preparation, their use as a medicament, and medicament containing them
|
|
DE10163992A1
(de)
|
2001-12-24 |
2003-07-03 |
Merck Patent Gmbh |
4-Aryl-chinazoline
|
|
US7119120B2
(en)
|
2001-12-26 |
2006-10-10 |
Genzyme Corporation |
Phosphate transport inhibitors
|
|
ATE337326T1
(de)
|
2002-03-19 |
2006-09-15 |
Genzyme Corp |
Hemmer des phosphattransports
|
|
US20050176746A1
(en)
|
2002-05-17 |
2005-08-11 |
Frank Weber |
Use of compounds that are effective as selective opiate receptor modulators
|
|
US7014862B2
(en)
|
2002-05-20 |
2006-03-21 |
The Procter & Gamble Company |
Chewable compositions containing a gel-forming extract of psyllium
|
|
US6923466B2
(en)
|
2002-12-17 |
2005-08-02 |
James Tsai |
Collapsible handcart capable of extending the area of carrier by operating handle
|
|
US7304036B2
(en)
|
2003-01-28 |
2007-12-04 |
Microbia, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
US20050054705A1
(en)
|
2003-02-04 |
2005-03-10 |
Aventis Pharma Deutschland Gmbh |
N-substituted (benzoimidazol-2-yl) phenylamines, process for their preparation, their use as medicament or diagnostic aid, and medicament comprising them
|
|
US7026303B2
(en)
|
2003-02-18 |
2006-04-11 |
The Procter & Gamble Company |
Compositions comprising a polysaccharide component and one or more coating layers
|
|
WO2004085448A2
(en)
|
2003-03-19 |
2004-10-07 |
Genzyme Corporation |
Unsaturated phosphinyl-phosphonate phosphate transport inhibitors
|
|
DE10312963A1
(de)
*
|
2003-03-24 |
2004-10-07 |
Aventis Pharma Deutschland Gmbh |
Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
|
|
US7241775B2
(en)
|
2003-03-24 |
2007-07-10 |
Sanofi-Aventis Deutschland Gmbh |
Composition, process of making, and medical use of substituted 4-phenyltetrahydroisoquinolines
|
|
WO2004085382A1
(ja)
|
2003-03-27 |
2004-10-07 |
Kirin Beer Kabushiki Kaisha |
生体内リン輸送を阻害する化合物およびそれを含んでなる医薬
|
|
US20050244367A1
(en)
|
2004-05-03 |
2005-11-03 |
Ilypsa, Inc. |
Phospholipase inhibitors localized in the gastrointestinal lumen
|
|
BRPI0511127A
(pt)
|
2004-05-14 |
2007-11-27 |
Univ North Carolina |
prouroguanilina e análogos sintéticos ou produtos da clivagem proteolìtica dela derivados, como agentes terapêuticos e de diagnósticos para doenças que envolvem a homeostasia de sal e/ou de lìquidos
|
|
DE102004046492A1
(de)
|
2004-09-23 |
2006-03-30 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
|
|
DE102004054847A1
(de)
|
2004-11-13 |
2006-05-24 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
|
DE102005001411A1
(de)
|
2005-01-12 |
2006-07-27 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
|
|
DE102005044817A1
(de)
|
2005-09-20 |
2007-03-22 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
|
|
DE102005044815A1
(de)
|
2005-09-20 |
2007-03-22 |
Sanofi-Aventis Deutschland Gmbh |
Verwendung von Inhibitoren des Na+/H+ Austauschers, Subtyp 5 (NHE5) zur Gedächtnisverbesserung
|
|
MX2008005661A
(es)
|
2005-11-03 |
2008-12-15 |
Ilypsa Inc |
Inhibidores de fosfolipasa, que incluyen inhibidores de fosfolipasa multivalente, y uso de los mismos, que incluyen como inhibidores de fosfolipasa localizadas en el lumen.
|
|
US7666898B2
(en)
|
2005-11-03 |
2010-02-23 |
Ilypsa, Inc. |
Multivalent indole compounds and use thereof as phospholipase-A2 inhibitors
|
|
US20120283411A9
(en)
|
2006-06-29 |
2012-11-08 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
US8779090B2
(en)
|
2007-02-26 |
2014-07-15 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of heart failure and other disorders
|
|
RU2009144972A
(ru)
|
2007-05-04 |
2011-06-10 |
Айронвуд Фармасьютикалз, Инк. (Us) |
Композиции и способы лечения нарушений, ассоциированных с задержкой соли или жидкости
|
|
BRPI0918502A2
(pt)
*
|
2008-09-02 |
2015-12-01 |
Sanofi Aventis |
aminoindanos substituídos e análogos dos mesmos, e o uso farmacêutico dos mesmos
|
|
SI2384318T1
(en)
*
|
2008-12-31 |
2018-03-30 |
Ardelyx, Inc. |
MEASURES AND PROCEDURES FOR THE INHIBITION OF ANTIPORT INHIBITED BY NHE IN THE TREATMENT OF DISEASES RELATED TO STRENGTH OF FLAMMABILITY OR TRADEMARITY WITH SOLO, AND THE EMISSION OF GASTROINTESTINAL TREATMENT
|
|
WO2012006477A1
(en)
*
|
2010-07-07 |
2012-01-12 |
Ardelyx, Inc. |
Compounds and methods for inhibiting phosphate transport
|
|
JP5823514B2
(ja)
|
2010-07-07 |
2015-11-25 |
アーデリクス，インコーポレーテッド |
リン酸輸送を阻害する化合物及び方法
|
|
EP2590655B1
(en)
|
2010-07-07 |
2015-06-24 |
Ardelyx, Inc. |
Compounds and methods for inhibiting phosphate transport
|
|
WO2012006475A1
(en)
|
2010-07-07 |
2012-01-12 |
Ardelyx, Inc. |
Compounds and methods for inhibiting phosphate transport
|
|
BR112015003516A2
(pt)
*
|
2012-08-21 |
2017-07-04 |
Ardelyx Inc |
compostos e métodos para inibição de antiporte mediado por nhe no tratamento de transtornos associados à retenção de fluido ou sobrecarga de sal e transtornos do trato gastrintestinal
|
|
MX366293B
(es)
*
|
2012-08-21 |
2019-07-04 |
Ardelyx Inc |
Compuestos y metodos para inhibir al antipuerto mediado por nhe en el tratamiento de trastornos asociados con la retencion de fluidos o la sobrecarga de sal y trastornos del tracto gastrointestinal.
|
|
LT2983667T
(lt)
|
2013-04-12 |
2019-07-10 |
Ardelyx, Inc. |
Nhe3 rišantys junginiai ir fosfato pernešimo slopinimo būdai
|